Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
Identifieur interne : 003056 ( Main/Exploration ); précédent : 003055; suivant : 003057Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.
Auteurs : G Mani Subramanian [États-Unis] ; Paul A. Moore ; Brian B. Gowen ; Aaron L. Olsen ; Dale L. Barnard ; Jason Paragas ; Robert J. Hogan ; Robert W. SidwellSource :
- Chemotherapy [ 1421-9794 ] ; 2008.
Descripteurs français
- KwdFr :
- Animaux, Antiviraux (pharmacologie), Bioterrorisme, Ebolavirus (), Ebolavirus (physiologie), Interféron alpha (pharmacologie), Interféron bêta (pharmacologie), Interféron de type I (pharmacologie), Lignée cellulaire, Protéines de fusion recombinantes (pharmacologie), Protéines recombinantes, Réplication virale (), Virus du SRAS (), Virus du SRAS (physiologie).
- MESH :
- pharmacologie : Antiviraux, Interféron alpha, Interféron bêta, Interféron de type I, Protéines de fusion recombinantes.
- physiologie : Ebolavirus, Virus du SRAS.
- Animaux, Bioterrorisme, Ebolavirus, Lignée cellulaire, Protéines recombinantes, Réplication virale, Virus du SRAS.
English descriptors
- KwdEn :
- Animals, Antiviral Agents (pharmacology), Bioterrorism, Cell Line, Chlorocebus aethiops, Ebolavirus (drug effects), Ebolavirus (physiology), Interferon Type I (pharmacology), Interferon-alpha (pharmacology), Interferon-beta (pharmacology), Recombinant Fusion Proteins (pharmacology), Recombinant Proteins, SARS Virus (drug effects), SARS Virus (physiology), Virus Replication (drug effects).
- MESH :
- chemical , pharmacology : Antiviral Agents, Interferon Type I, Interferon-alpha, Interferon-beta, Recombinant Fusion Proteins.
- drug effects : Ebolavirus, SARS Virus, Virus Replication.
- physiology : Ebolavirus, SARS Virus.
- Animals, Bioterrorism, Cell Line, Chlorocebus aethiops, Recombinant Proteins.
Abstract
The type 1 interferons (INF-alpha and INF-beta) are potent antiviral agents. Albumin-INF-alpha and albumin-INF-beta are novel recombinant proteins consisting of IFN-alpha or IFN-beta genetically fused to human albumin.
DOI: 10.1159/000140361
PubMed: 18560223
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001B21
- to stream PubMed, to step Curation: 001B21
- to stream PubMed, to step Checkpoint: 001A61
- to stream Ncbi, to step Merge: 001C79
- to stream Ncbi, to step Curation: 001C79
- to stream Ncbi, to step Checkpoint: 001C79
- to stream Main, to step Merge: 003129
- to stream Main, to step Curation: 003056
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.</title>
<author><name sortKey="Subramanian, G Mani" sort="Subramanian, G Mani" uniqKey="Subramanian G" first="G Mani" last="Subramanian">G Mani Subramanian</name>
<affiliation wicri:level="2"><nlm:affiliation>Human Genome Sciences, Inc., Rockville, MD 20850, USA. Mani_Subramanian@hgsi.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Human Genome Sciences, Inc., Rockville, MD 20850</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moore, Paul A" sort="Moore, Paul A" uniqKey="Moore P" first="Paul A" last="Moore">Paul A. Moore</name>
</author>
<author><name sortKey="Gowen, Brian B" sort="Gowen, Brian B" uniqKey="Gowen B" first="Brian B" last="Gowen">Brian B. Gowen</name>
</author>
<author><name sortKey="Olsen, Aaron L" sort="Olsen, Aaron L" uniqKey="Olsen A" first="Aaron L" last="Olsen">Aaron L. Olsen</name>
</author>
<author><name sortKey="Barnard, Dale L" sort="Barnard, Dale L" uniqKey="Barnard D" first="Dale L" last="Barnard">Dale L. Barnard</name>
</author>
<author><name sortKey="Paragas, Jason" sort="Paragas, Jason" uniqKey="Paragas J" first="Jason" last="Paragas">Jason Paragas</name>
</author>
<author><name sortKey="Hogan, Robert J" sort="Hogan, Robert J" uniqKey="Hogan R" first="Robert J" last="Hogan">Robert J. Hogan</name>
</author>
<author><name sortKey="Sidwell, Robert W" sort="Sidwell, Robert W" uniqKey="Sidwell R" first="Robert W" last="Sidwell">Robert W. Sidwell</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18560223</idno>
<idno type="pmid">18560223</idno>
<idno type="doi">10.1159/000140361</idno>
<idno type="wicri:Area/PubMed/Corpus">001B21</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001B21</idno>
<idno type="wicri:Area/PubMed/Curation">001B21</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001B21</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001A61</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A61</idno>
<idno type="wicri:Area/Ncbi/Merge">001C79</idno>
<idno type="wicri:Area/Ncbi/Curation">001C79</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001C79</idno>
<idno type="wicri:Area/Main/Merge">003129</idno>
<idno type="wicri:Area/Main/Curation">003056</idno>
<idno type="wicri:Area/Main/Exploration">003056</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus.</title>
<author><name sortKey="Subramanian, G Mani" sort="Subramanian, G Mani" uniqKey="Subramanian G" first="G Mani" last="Subramanian">G Mani Subramanian</name>
<affiliation wicri:level="2"><nlm:affiliation>Human Genome Sciences, Inc., Rockville, MD 20850, USA. Mani_Subramanian@hgsi.com</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Human Genome Sciences, Inc., Rockville, MD 20850</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moore, Paul A" sort="Moore, Paul A" uniqKey="Moore P" first="Paul A" last="Moore">Paul A. Moore</name>
</author>
<author><name sortKey="Gowen, Brian B" sort="Gowen, Brian B" uniqKey="Gowen B" first="Brian B" last="Gowen">Brian B. Gowen</name>
</author>
<author><name sortKey="Olsen, Aaron L" sort="Olsen, Aaron L" uniqKey="Olsen A" first="Aaron L" last="Olsen">Aaron L. Olsen</name>
</author>
<author><name sortKey="Barnard, Dale L" sort="Barnard, Dale L" uniqKey="Barnard D" first="Dale L" last="Barnard">Dale L. Barnard</name>
</author>
<author><name sortKey="Paragas, Jason" sort="Paragas, Jason" uniqKey="Paragas J" first="Jason" last="Paragas">Jason Paragas</name>
</author>
<author><name sortKey="Hogan, Robert J" sort="Hogan, Robert J" uniqKey="Hogan R" first="Robert J" last="Hogan">Robert J. Hogan</name>
</author>
<author><name sortKey="Sidwell, Robert W" sort="Sidwell, Robert W" uniqKey="Sidwell R" first="Robert W" last="Sidwell">Robert W. Sidwell</name>
</author>
</analytic>
<series><title level="j">Chemotherapy</title>
<idno type="eISSN">1421-9794</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Antiviral Agents (pharmacology)</term>
<term>Bioterrorism</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Ebolavirus (drug effects)</term>
<term>Ebolavirus (physiology)</term>
<term>Interferon Type I (pharmacology)</term>
<term>Interferon-alpha (pharmacology)</term>
<term>Interferon-beta (pharmacology)</term>
<term>Recombinant Fusion Proteins (pharmacology)</term>
<term>Recombinant Proteins</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (physiology)</term>
<term>Virus Replication (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Antiviraux (pharmacologie)</term>
<term>Bioterrorisme</term>
<term>Ebolavirus ()</term>
<term>Ebolavirus (physiologie)</term>
<term>Interféron alpha (pharmacologie)</term>
<term>Interféron bêta (pharmacologie)</term>
<term>Interféron de type I (pharmacologie)</term>
<term>Lignée cellulaire</term>
<term>Protéines de fusion recombinantes (pharmacologie)</term>
<term>Protéines recombinantes</term>
<term>Réplication virale ()</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (physiologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Interferon Type I</term>
<term>Interferon-alpha</term>
<term>Interferon-beta</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Ebolavirus</term>
<term>SARS Virus</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term>
<term>Interféron alpha</term>
<term>Interféron bêta</term>
<term>Interféron de type I</term>
<term>Protéines de fusion recombinantes</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Ebolavirus</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Ebolavirus</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Bioterrorism</term>
<term>Cell Line</term>
<term>Chlorocebus aethiops</term>
<term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Bioterrorisme</term>
<term>Ebolavirus</term>
<term>Lignée cellulaire</term>
<term>Protéines recombinantes</term>
<term>Réplication virale</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The type 1 interferons (INF-alpha and INF-beta) are potent antiviral agents. Albumin-INF-alpha and albumin-INF-beta are novel recombinant proteins consisting of IFN-alpha or IFN-beta genetically fused to human albumin.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Maryland</li>
</region>
</list>
<tree><noCountry><name sortKey="Barnard, Dale L" sort="Barnard, Dale L" uniqKey="Barnard D" first="Dale L" last="Barnard">Dale L. Barnard</name>
<name sortKey="Gowen, Brian B" sort="Gowen, Brian B" uniqKey="Gowen B" first="Brian B" last="Gowen">Brian B. Gowen</name>
<name sortKey="Hogan, Robert J" sort="Hogan, Robert J" uniqKey="Hogan R" first="Robert J" last="Hogan">Robert J. Hogan</name>
<name sortKey="Moore, Paul A" sort="Moore, Paul A" uniqKey="Moore P" first="Paul A" last="Moore">Paul A. Moore</name>
<name sortKey="Olsen, Aaron L" sort="Olsen, Aaron L" uniqKey="Olsen A" first="Aaron L" last="Olsen">Aaron L. Olsen</name>
<name sortKey="Paragas, Jason" sort="Paragas, Jason" uniqKey="Paragas J" first="Jason" last="Paragas">Jason Paragas</name>
<name sortKey="Sidwell, Robert W" sort="Sidwell, Robert W" uniqKey="Sidwell R" first="Robert W" last="Sidwell">Robert W. Sidwell</name>
</noCountry>
<country name="États-Unis"><region name="Maryland"><name sortKey="Subramanian, G Mani" sort="Subramanian, G Mani" uniqKey="Subramanian G" first="G Mani" last="Subramanian">G Mani Subramanian</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003056 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003056 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:18560223 |texte= Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:18560223" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
This area was generated with Dilib version V0.6.33. |